FDA Panels Recommend Approval of Abuse-Deterrent IR Oxycodone FDA Panels Recommend Approval of Abuse-Deterrent IR Oxycodone

Two FDA advisory committees voted 10-7 for recommending approval for a new abuse-deterrent formulation of immediate-release (IR) oxycodone to treat adult patients with severe pain.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news